August 2022
154 articles-
Aug 31 · 03:26Biotechnology Daily
A change of heart: Individual genetic factors could lead to customized cardiac therapies
-
Aug 31 · 03:24Biotechnology Daily
Glaukos nets FDA clearance for latest pressure-relieving glaucoma eye stent
-
Aug 31 · 03:23Biotechnology Daily
New 'off-the-shelf' stem cell CAR-T to be the basis of company born out of Boston Children’s Hospital and ElevateBio
-
Aug 31 · 03:21Biotechnology Daily
Tandem lines up FDA review of new pint-sized insulin pump amid lower-than-expected sales
-
Aug 31 · 03:16Bio Business News
Lilly 'won't be discouraged' if others fail in Alzheimer's, neuroscience chief says
-
Aug 31 · 03:09Bio Business News
Pieris trims fat with phase 2 cancer drug culls to focus on AstraZeneca asthma collab
-
Aug 31 · 03:07Bio Business News
Looking east, Sanofi pens 'pioneering' cancer drug partnership with China's Innovent
-
Aug 31 · 02:49Bio Business News
Gilead pays out $405M for a chance to compete with Eli Lilly's BTLA program
-
-
Aug 31 · 01:48Market Watch
AT&T Inc. stock rises Tuesday, outperforms market
-
Aug 30 · 12:28Biotechnology Daily
Intellia tacks on lower dose to polyneuropathy trial arm after elevated liver level in one patient
-
Aug 30 · 12:27Biotechnology Daily
Virtual reality tech helps separate conjoined twins in Brazil
-
Aug 30 · 12:26Biotechnology Daily
Stryker opens 3D printing facility in Ireland, promising 600 new jobs
-
Aug 30 · 12:24Biotechnology Daily
Late to the CAR-T game, AstraZeneca quietly works on its own off-the-shelf therapies
-
Aug 30 · 12:22Bio Business News
Thinning its $11B Array of options, Pfizer drops cardiology drug after phase 3 fails futility check
-
Aug 30 · 12:21Bio Business News
Amgen hits pause on $400M eczema bet to tweak phase 3 study
-
Aug 30 · 12:20Bio Business News
Clean up on IL-2: Moderna mops up autoimmune asset after peeking at early data
-
Aug 30 · 12:18Bio Business News
Exact Sciences hands over Oncotype prostate cancer test to MDxHealth for $30M upfront
-
Aug 19 · 01:20Market Watch
Bill.com's stock soars 17% on strong results, revenue guidance
-
Aug 18 · 05:54Biotechnology Daily
European probe into Illumina's Grail deal can proceed, EU court rules
-
Aug 18 · 05:52Biotechnology Daily
Summit will take scenic route up FDA mountain after regulator recommends more trials for C. diff therapy
-
Aug 18 · 05:50Biotechnology Daily
ContraFect halts phase 3 after antimicrobial fails futility test against MRSA
-
Aug 18 · 05:49Biotechnology Daily
Breaking the vicious itch-scratch cycle by targeting 'miswired' neurons
-
Aug 18 · 05:47Bio Business News
Novartis links up with Mayo Clinic spinout Anumana to develop ECG-reading AI